康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00867 康哲药业

已收盘 11-19 16:08:17

7.700

-0.030

-0.39%

最高7.930	最低7.550	成交量639.79万
今开7.900	昨收7.730	日振幅4.92%
总市值187.84亿	流通市值187.84亿	总股本24.40亿
成交额4,907万	换手率0.26%	流通股本24.40亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00867","market":"HK","secType":"STK","nameCN":"康哲药业","latestPrice":7.7,"timestamp":1732003697010,"preClose":7.73,"halted":0,"volume":6397920,"delay":0,"floatShares":2439528512,"shares":2439528512,"eps":1.0525713,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.03,"latestTime":"11-19 16:08:17","open":7.9,"high":7.93,"low":7.55,"amount":49072567,"amplitude":0.049159,"askPrice":7.7,"askSize":140000,"bidPrice":7.69,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":0.611210040086851,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732066200000},"adr":0,"adjPreClose":7.73,"dividendRate":0.032014,"openAndCloseTimeList":[[1731979800000,1731988800000],[1731992400000,1732003200000]],"volumeRatio":1.477718,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00867","defaultTab":"news","newsList":[{"id":"2482411724","title":"康哲药业11月12日遭主力抛售132万元 环比增加842.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482411724","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482411724?lang=zh_cn&edition=full","pubTime":"2024-11-12 16:15","pubTimestamp":1731399353,"startTime":"0","endTime":"0","summary":"11月12日, 康哲药业股价跌0.90%，报收7.69元，成交金额3896万元，换手率0.21%，振幅4.12%，量比1.38。康哲药业今日主力资金净流出132万元，上一交易日主力净流出14万元，今日环比增加842.86%。该股近5个交易日下跌0.87%，主力资金累计净流入132万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1683万元，其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112161729a22fa9b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112161729a22fa9b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BYV24P56.USD","BK1593","SG9999015952.SGD","SG9999015978.USD","IE00BMCWC346.EUR","SG9999015945.SGD","SG9999004220.SGD","SG9999015986.USD","LU2488822045.USD","00867","BK1191"],"gpt_icon":0},{"id":"2481667039","title":"康哲药业新药磷酸芦可替尼乳膏获中国香港批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2481667039","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481667039?lang=zh_cn&edition=full","pubTime":"2024-11-06 08:45","pubTimestamp":1730853927,"startTime":"0","endTime":"0","summary":"财中社11月6日电康哲药业（00867）发布公告，宣布磷酸芦可替尼乳膏（白癜风适应症）的新药上市申请已于2024年11月4日获得香港政府药剂业及毒药管理局批准，并于11月5日收到药品注册证明书。该产品用于治疗12岁及以上青少年和成人患者伴面部受累的非节段型白癜风，填补了市场上对该疾病治疗的需求。芦可替尼乳膏在美国已获得FDA批准，成为首个用于局部治疗非节段型白癜风的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411063230274176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","SG9999015945.SGD","SG9999015952.SGD","IE00BMCWC346.EUR","SG9999015978.USD","BK1593","00867","SG9999015986.USD","IE00BYV24P56.USD","SG9999004220.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2481655692","title":"康哲药业(00867.HK)磷酸芦可替尼乳膏香港新药上市申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2481655692","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481655692?lang=zh_cn&edition=full","pubTime":"2024-11-06 04:44","pubTimestamp":1730839440,"startTime":"0","endTime":"0","summary":"康哲药业(00867.HK) 公布，香港政府药剂业及毒药管理局批准磷酸芦可替尼乳膏新药上市申请。该产品用于治疗12岁及以上青少年和成人患者伴面部受累的非节段型白癜风。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-05 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230303150405882_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230303150405882_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1394365/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["SG9999015952.SGD","IE00BYV24P56.USD","IE00BMCWC346.EUR","SG9999004220.SGD","SG9999015978.USD","BK1593","00867","LU2488822045.USD","SG9999015945.SGD","BK1191","SG9999015986.USD"],"gpt_icon":0},{"id":"2481500391","title":"康哲药业(00867)：磷酸芦可替尼乳膏(白癜风适应症)香港新药上市申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2481500391","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481500391?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:28","pubTimestamp":1730816924,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业(00867)发布公告，中国香港特别行政区政府药剂业及毒药管理局(PPBHK)已于2024年11月4日批准磷酸芦可替尼乳膏新药上市申请，于2024年11月5日收到药品/制品注册证明书。产品用于治疗12岁及以上青少年和成人患者伴面部受累的非节段型白癜风。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1207171.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BYV24P56.USD","BK1593","IE00BMCWC346.EUR","SG9999015986.USD","00867","SG9999015952.SGD","LU2488822045.USD","BK1191","SG9999015978.USD","SG9999004220.SGD","SG9999015945.SGD"],"gpt_icon":0},{"id":"2479248977","title":"康哲药业(00867)下跌5.09%，报7.83元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2479248977","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479248977?lang=zh_cn&edition=full","pubTime":"2024-10-30 13:10","pubTimestamp":1730265058,"startTime":"0","endTime":"0","summary":"10月30日，康哲药业(00867)盘中下跌5.09%，截至13:10，报7.83元/股，成交3117.13万元。康哲药业控股有限公司主要业务是与全球生物科技和制药公司合作，开发全球首创和同类最优的创新产品，专注于心脑血管、消化、中枢神经、皮肤/医美、眼科、儿科等专科疾病领域。公司在过去十五年(2008-2022)的销售额和净利润的年度复合增长率均超过20%，并通过专科线分拆独立运营，整合专科疾病领域优势资源，推动集团高质量、可持续的健康发展。截至2024年中报，康哲药业营业总收入36.11亿元、净利润9.1亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/30131044714464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE00BYV24P56.USD","BK1593","SG9999015952.SGD","SG9999015978.USD","IE00BMCWC346.EUR","SG9999015945.SGD","SG9999004220.SGD","SG9999015986.USD","LU2488822045.USD","00867","BK1191"],"gpt_icon":0},{"id":"2479124338","title":"康哲药业盘中异动 急速下挫5.09%报7.830港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479124338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479124338?lang=zh_cn&edition=full","pubTime":"2024-10-30 13:10","pubTimestamp":1730265054,"startTime":"0","endTime":"0","summary":"2024年10月30日下午盘13时10分，康哲药业股票出现异动，股价急速下跌5.09%。截至发稿，该股报7.830港元/股，成交量389.3万股，换手率0.16%，振幅4.61%。资金方面，该股资金流入1142.55万港元，流出1760.58万港元。康哲药业股票所在的药品行业中，整体跌幅为0.59%。其相关个股中，泰凌医药、德琪医药-B、白花油涨幅较大，振幅较大的相关个股有艾美疫苗、翰森制药、康龙化成，振幅分别为11.00%、10.27%、8.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103013105498e3f4e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103013105498e3f4e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015986.USD","LU2488822045.USD","SG9999004220.SGD","SG9999015945.SGD","SG9999015952.SGD","IE00BYV24P56.USD","BK1593","BK1191","00867","SG9999015978.USD","IE00BMCWC346.EUR"],"gpt_icon":0},{"id":"2477537408","title":"康哲药业10月23日主力资金流入402万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2477537408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477537408?lang=zh_cn&edition=full","pubTime":"2024-10-23 16:15","pubTimestamp":1729671321,"startTime":"0","endTime":"0","summary":"10月23日, 康哲药业股价跌0.47%，报收8.50元，成交金额3711万元，换手率0.18%，振幅2.58%，量比0.71。康哲药业今日主力资金净流入402万元，连续3日净流入，上一交易日主力净流入131万元，今日环比增加206.87%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为58.33%，平均涨幅为1.43%。该股近5个交易日上涨1.44%，主力资金累计净流出1748万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流出808万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410231615389f589562&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410231615389f589562&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015986.USD","LU2488822045.USD","SG9999004220.SGD","SG9999015945.SGD","SG9999015952.SGD","IE00BYV24P56.USD","BK1593","BK1191","00867","SG9999015978.USD","IE00BMCWC346.EUR"],"gpt_icon":0},{"id":"2477801758","title":"康哲药业10月22日获主力加仓131万元 环比增加4266.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477801758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477801758?lang=zh_cn&edition=full","pubTime":"2024-10-22 16:15","pubTimestamp":1729584942,"startTime":"0","endTime":"0","summary":"10月22日, 康哲药业股价涨0.35%，报收8.54元，成交金额3296万元，换手率0.16%，振幅3.88%，量比0.54。康哲药业今日主力资金净流入131万元，上一交易日主力净流入3万元，今日环比增加4266.67%。该股近5个交易日上涨2.20%，主力资金累计净流出2156万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出1295万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102216160395bab6e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102216160395bab6e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","SG9999015986.USD","BK1593","SG9999004220.SGD","LU2488822045.USD","IE00BYV24P56.USD","00867","SG9999015952.SGD","IE00BMCWC346.EUR","SG9999015945.SGD","SG9999015978.USD"],"gpt_icon":0},{"id":"2477602550","title":"南向资金10月18日净卖出康哲药业46.24万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2477602550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477602550?lang=zh_cn&edition=full","pubTime":"2024-10-21 09:30","pubTimestamp":1729474210,"startTime":"0","endTime":"0","summary":"10月18日，南向资金减持康哲药业46.24万股连续5日减持。截止当日收盘，港股通共持有康哲药业22163.28万股，占流通股9.07%。康哲药业近5个交易日下跌3.52%，港股通累计减持442.04万股；近20个交易日上涨15.22%，港股通累计增持699.06万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102109310695b75c5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102109310695b75c5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BYV24P56.USD","SG9999015986.USD","BK1593","SG9999015945.SGD","LU2488822045.USD","BK1191","SG9999015978.USD","00867","SG9999015952.SGD","IE00BMCWC346.EUR","SG9999004220.SGD"],"gpt_icon":0},{"id":"2476389027","title":"施美药业IPO：战投方变大客户，入股定价公允性引监管质疑","url":"https://stock-news.laohu8.com/highlight/detail?id=2476389027","media":"地产k线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476389027?lang=zh_cn&edition=full","pubTime":"2024-10-19 15:37","pubTimestamp":1729323450,"startTime":"0","endTime":"0","summary":"瑞财经张林霞 近日，江西施美药业股份有限公司（以下简称“施美药业”）正在闯关创业板，排队逾一年。目前，施美药业创业板IPO处于二轮问询阶段，还未有新进展。全国工商联医药业商会理事、研发及服务专业委员会副主任、广东省药理学会药物筛选与评价专业委员会常务委员、南方医科大学客座教授、广州医科大学兼职教授.......","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OQViRXOrQFVqqKL-WhC1tq5AxgS0XpGxNS1kgoRnUOpVEAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OQViRXOrQFVqqKL-WhC1tq5AxgS0XpGxNS1kgoRnUOpVEAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241019A05AXY00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241019A05AXY00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["SG9999004220.SGD","00867","SG9999015952.SGD","SG9999015945.SGD","SG9999015986.USD","IE00BYV24P56.USD","IE00BMCWC346.EUR","SG9999015978.USD","BK1593","LU2488822045.USD","BK1191"],"gpt_icon":0},{"id":"2476021426","title":"康哲药业(00867)上涨5.05%，报8.73元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2476021426","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476021426?lang=zh_cn&edition=full","pubTime":"2024-10-18 14:18","pubTimestamp":1729232303,"startTime":"0","endTime":"0","summary":"10月18日，康哲药业(00867)盘中上涨5.05%，截至14:18，报8.73元/股，成交4431.73万元。康哲药业控股有限公司主要业务是与全球生物科技和制药公司合作，开发全球首创和同类最优的创新产品，专注于心脑血管、消化、中枢神经、皮肤/医美、眼科、儿科等专科疾病领域。公司在过去十五年(2008-2022)的销售额和净利润的年度复合增长率均超过20%，并通过专科线分拆独立运营，整合专科疾病领域优势资源，推动集团高质量、可持续的健康发展。截至2024年中报，康哲药业营业总收入36.11亿元、净利润9.1亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/18141844150676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE00BYV24P56.USD","SG9999004220.SGD","SG9999015945.SGD","00867","SG9999015986.USD","SG9999015952.SGD","IE00BMCWC346.EUR","LU2488822045.USD","BK1191","SG9999015978.USD","BK1593"],"gpt_icon":0},{"id":"2476429220","title":"康哲药业盘中异动 下午盘大幅拉升5.05%报8.730港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476429220","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476429220?lang=zh_cn&edition=full","pubTime":"2024-10-18 14:18","pubTimestamp":1729232300,"startTime":"0","endTime":"0","summary":"2024年10月18日下午盘14时18分，康哲药业股票出现波动，股价急速上涨5.05%。截至发稿，该股报8.730港元/股，成交量525.98万股，换手率0.22%，振幅5.17%。资金方面，该股资金流入1455.47万港元，流出2547.66万港元。康哲药业股票所在的药品行业中，整体涨幅为0.69%。其相关个股中，康龙化成、德琪医药-B、凯莱英涨幅较大，振幅较大的相关个股有华控康泰、三爱健康集团、联康生物科技集团，振幅分别为14.29%、13.33%、11.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018141820ab6b0d7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018141820ab6b0d7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","SG9999015986.USD","00867","LU2488822045.USD","BK1593","IE00BMCWC346.EUR","SG9999004220.SGD","SG9999015952.SGD","SG9999015945.SGD","SG9999015978.USD","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2476680443","title":"研报新知｜治疗白癜风的首款处方药即将获批，这家药企值得关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2476680443","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476680443?lang=zh_cn&edition=full","pubTime":"2024-10-18 12:00","pubTimestamp":1729224000,"startTime":"0","endTime":"0","summary":"中国约有1400万白癜风患者，存在巨大的未满足临床需求。全球仅有芦可替尼乳膏获批用于白癜风的治疗，成药性明确。该药物于2024年9月在国内递交了上市申请并已获受理，有望成为首个在中国上市的白癜风治疗处方药。国内开发这款药的正是这家公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101812014295b11267&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101812014295b11267&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015945.SGD","SG9999015986.USD","IE00BYV24P56.USD","SG9999015952.SGD","SG9999015978.USD","00867","LU2488822045.USD","BK1191","IE00BMCWC346.EUR","BK1593","SG9999004220.SGD"],"gpt_icon":0},{"id":"2476877321","title":"南向资金10月16日净卖出康哲药业124.70万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2476877321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476877321?lang=zh_cn&edition=full","pubTime":"2024-10-17 09:30","pubTimestamp":1729128609,"startTime":"0","endTime":"0","summary":"10月16日，南向资金减持康哲药业124.70万股连续3日减持。截止当日收盘，港股通共持有康哲药业22259.92万股，占流通股9.12%。康哲药业近5个交易日下跌10.99%，港股通累计减持322.10万股；近20个交易日上涨11.35%，港股通累计增持830.70万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410170930379f48f271&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410170930379f48f271&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015952.SGD","SG9999015986.USD","SG9999015945.SGD","BK1191","LU2488822045.USD","IE00BMCWC346.EUR","IE00BYV24P56.USD","BK1593","SG9999004220.SGD","00867","SG9999015978.USD"],"gpt_icon":0},{"id":"2475533001","title":"港股异动 | 康哲药业(01681)早盘涨近8% 芦可替尼乳膏上市有望填补国内白癜风市场空白 集采影响基本出清","url":"https://stock-news.laohu8.com/highlight/detail?id=2475533001","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475533001?lang=zh_cn&edition=full","pubTime":"2024-10-15 11:38","pubTimestamp":1728963536,"startTime":"0","endTime":"0","summary":"中信建投指出，公司磷酸芦可替尼乳膏上市申请获受理，未来上市有望填补国内白癜风市场空白，凭借中国及东亚2050万的白癜风患者，芦可替尼乳膏未来放量可期，有望成为公司的核心产品。西南证券指出，康哲药业集采影响基本出清，业绩拐点已现，2024年上半年全按药品销售收入环比增长8.9%，期间溢利环比增长92.8%。随着收入和利润增速环比的提升，我们认为集采负面影响基本出清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1193976.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","LU2488822045.USD","SG9999015978.USD","01681","IE00BMCWC346.EUR","00867","IE00BYV24P56.USD","SG9999015945.SGD","SG9999004220.SGD","SG9999015952.SGD","BK1606","BK1593","SG9999015986.USD"],"gpt_icon":0},{"id":"2474737236","title":"施美药业IPO被审计机构拖累，江鸿赌输了6000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474737236","media":"市场投研资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474737236?lang=zh_cn&edition=full","pubTime":"2024-10-10 10:10","pubTimestamp":1728526200,"startTime":"0","endTime":"0","summary":"据瑞财经《预审IPO》了解，施美药业此前的审计机构天职国际因存在伪造、篡改、毁损审计工作底稿的行为，被中国证监会采取了责令改正、给予警告的措施，同时被没收业务收入367.92万元，处以2339.62万元罚款，并被处暂停从事证券服务业务6个月。其中，江鸿受让90%，江样其受让10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-10-10/doc-incrzpza8807859.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-10-10/doc-incrzpza8807859.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","SG9999015945.SGD","SG9999015952.SGD","IE00BMCWC346.EUR","SG9999015978.USD","BK1593","00867","SG9999015986.USD","IE00BYV24P56.USD","SG9999004220.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2474583252","title":"康哲药业盘中异动 急速跳水5.02%报8.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474583252","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474583252?lang=zh_cn&edition=full","pubTime":"2024-10-09 11:10","pubTimestamp":1728443443,"startTime":"0","endTime":"0","summary":"2024年10月09日早盘11时10分，康哲药业股票出现异动，股价大幅下挫5.02%。截至发稿，该股报8.900港元/股，成交量363.2万股，换手率0.15%，振幅7.79%。资金方面，该股资金流入1484.93万港元，流出1538.15万港元。最近的财报数据显示，该股实现营业收入39.57亿港元，净利润9.98亿港元，每股收益0.41港元，毛利29.54亿港元，市盈率8.19倍。康哲药业股票所在的药品行业中，整体跌幅为0.86%。消息层面，截至11时10分，康哲药业股票正面舆情新闻比例33.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410091110439719f28a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410091110439719f28a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00867","BK1191","IE00BMCWC346.EUR","SG9999015945.SGD","BK1593","SG9999015952.SGD","SG9999015978.USD","SG9999015986.USD","LU2488822045.USD","SG9999004220.SGD","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2473904984","title":"【券商聚焦】中信建投首予康哲药业(00867)“买入”评级 看好公司未来创新转型及发展潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2473904984","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473904984?lang=zh_cn&edition=full","pubTime":"2024-10-08 14:27","pubTimestamp":1728368859,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投发研报指，康哲药业 磷酸芦可替尼乳膏上市申请获受理，未来上市有望填补国内白癜风市场空白，凭借中国及东亚2050万的白癜风患者，芦可替尼乳膏未来放量可期，有望成为公司的核心产品。未来随着芦可替尼乳膏的获批上市及后续创新管线稳步推进，看好公司未来创新转型及发展潜力。实现归母净利润17.9、21.2以及26.2亿元，同比增长-25.45%、18.63%以及23.18%，对应PE 9.81、8.27以及6.71倍，首次覆盖，给予“买入”评级。","market":"other","thumbnail":"https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1945514","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"gpt_icon":0},{"id":"2473635490","title":"康哲药业(00867)股价下跌5.04%，现价港币$9.42","url":"https://stock-news.laohu8.com/highlight/detail?id=2473635490","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473635490?lang=zh_cn&edition=full","pubTime":"2024-10-08 14:15","pubTimestamp":1728368100,"startTime":"0","endTime":"0","summary":"[下跌股]康哲药业(00867) 股价在下午02:15比前收市价下跌5.04%，现股价为港币$9.42。至目前为止，今日最高价为$9.98，而最低价为$8.89。总成交量为2.015千万股，总成交金额为港币$1.917亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD24100815797/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["IE00BYV24P56.USD","BK1593","SG9999015952.SGD","SG9999015978.USD","IE00BMCWC346.EUR","SG9999015945.SGD","SG9999004220.SGD","SG9999015986.USD","LU2488822045.USD","00867","BK1191"],"gpt_icon":0},{"id":"2473457112","title":"康哲药业盘中异动 大幅下挫5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473457112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473457112?lang=zh_cn&edition=full","pubTime":"2024-10-08 09:30","pubTimestamp":1728351009,"startTime":"0","endTime":"0","summary":"2024年10月08日早盘09时30分，康哲药业股票出现异动，股价急速下跌5.44%。截至发稿，该股报9.380港元/股，成交量12.7517万股，换手率0.01%，振幅1.01%。资金方面，该股资金流入15.98万港元，流出14.053万港元。康哲药业股票所在的药品行业中，整体涨幅为0.66%。其相关个股中，华控康泰、长江生命科技、艾美疫苗涨幅较大，振幅较大的相关个股有华控康泰、兆科眼科-B、信达生物，振幅分别为16.22%、5.49%、4.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008093010a1dec89c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008093010a1dec89c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","SG9999015952.SGD","LU2488822045.USD","00867","SG9999015978.USD","SG9999015945.SGD","SG9999004220.SGD","IE00BYV24P56.USD","SG9999015986.USD","IE00BMCWC346.EUR","BK1593"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cms.net.cn","stockEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":-0.1196},{"period":"3month","weight":0.1142},{"period":"6month","weight":0.1668},{"period":"1year","weight":-0.4135},{"period":"ytd","weight":-0.422}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.059},{"period":"3month","weight":0.118},{"period":"6month","weight":0.0198},{"period":"1year","weight":0.1216},{"period":"ytd","weight":0.1484}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康哲药业控股有限公司是一家主要从事医药产品的制造、推广、营销及销售业务的香港投资控股公司。其直接网络主要产品包括黛力新、优思弗、新活素、莎尔福、亿活及施图伦滴眼液等。其代理商推广网络产品包括沙多力卡、伊诺舒及喜达康等。其产品用于治疗胃病、心脏病、外伤感染、肝病及眼疾等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.011301},{"month":2,"riseRate":0.538462,"avgChangeRate":0.023837},{"month":3,"riseRate":0.5,"avgChangeRate":0.004124},{"month":4,"riseRate":0.5,"avgChangeRate":0.02223},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.008532},{"month":6,"riseRate":0.642857,"avgChangeRate":-0.002183},{"month":7,"riseRate":0.5,"avgChangeRate":-0.017299},{"month":8,"riseRate":0.428571,"avgChangeRate":0.023866},{"month":9,"riseRate":0.428571,"avgChangeRate":0.001076},{"month":10,"riseRate":0.533333,"avgChangeRate":0.011646},{"month":11,"riseRate":0.533333,"avgChangeRate":0.057681},{"month":12,"riseRate":0.642857,"avgChangeRate":0.043928}],"exchange":"SEHK","name":"康哲药业","nameEN":"CMS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康哲药业(00867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康哲药业,00867,康哲药业股票,康哲药业股票老虎,康哲药业股票老虎国际,康哲药业行情,康哲药业股票行情,康哲药业股价,康哲药业股市,康哲药业股票价格,康哲药业股票交易,康哲药业股票购买,康哲药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康哲药业(00867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}